Menu
Medical Condition
Ophthalmology / Eye Care
Ophthalmology / Eye Care ICD-10: H35.41

Lattice Degeneration

Peripheral retinal thinning characterized by arborizing white lines and focal vitreous attachments, increasing detachment risk.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

Often asymptomatic; may be discovered during routine dilated fundus examination.

General Examination

Unremarkable or not routinely indicated.

Treatment Protocol

Observation; prophylactic laser photocoagulation only if symptomatic or high-risk.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: Abdomen soft, non-tender. AR: البطن لين ولا يوجد ألم.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.

Dermatological

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Psychiatric

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

OB/GYN

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Ophthalmic

EN: Peripheral fundus shows circumferential areas of retinal thinning with sclerotic vessels. AR: يظهر محيط قاع العين مناطق دائرية من ترقق الشبكية مع أوعية دموية متصلبة.

Dental

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

1. Comprehensive Introduction & Overview

Lattice degeneration (LD) is a common, localized peripheral retinal thinning disorder characterized by well-defined, circumferential, spindle-shaped areas of retinal atrophy. Clinically, it is identified by its distinct crisscross pattern of white, sclerotic vessels, often surrounded by pigmentary changes. While historically viewed as a benign incidental finding, lattice degeneration is of critical importance in clinical ophthalmology due to its well-established association with rhegmatogenous retinal detachment (RRD).

Occurring in approximately 6% to 10% of the general population, lattice degeneration is bilateral in about 50% of cases. It primarily affects the peripheral retina, specifically the equatorial region, though it can extend anteriorly toward the ora serrata. The clinical significance of lattice degeneration stems from the interplay between the focal thinning of the inner retinal layers and the anomalous vitreoretinal adhesion at the margins of these lesions, which acts as a primary catalyst for retinal tears and subsequent detachment.

2. Deep-Dive: Technical Specifications and Mechanisms

Etiology and Pathophysiology

The precise etiology of lattice degeneration is considered multifactorial, involving a combination of developmental, degenerative, and mechanical factors. Pathologically, the condition is defined by:

  • Retinal Thinning: The inner retinal layers (inner nuclear layer through the internal limiting membrane) are attenuated or completely absent.
  • Vitreous Liquefaction: There is significant liquefaction of the overlying vitreous gel, which is a key contributor to the mechanical stress placed on the retina.
  • Vitreoretinal Adhesion: While the vitreous is liquefied over the lesion, the margins of the lattice area exhibit firm, anomalous vitreoretinal adhesions.
  • Sclerotic Vessels: The characteristic white, "lattice-like" appearance is created by the hyalinization and sclerosis of retinal arterioles.

The mechanical pathophysiology is driven by the dynamic vitreous. As the eye moves, the liquefied vitreous over the lattice lesion creates traction at the firm attachment points at the edges of the lesion. This focal traction can lead to the formation of small, round, atrophic holes within the lattice or, more dangerously, flap tears at the posterior margin of the lattice, leading to fluid ingress and retinal detachment.

Histopathology

Microscopic examination reveals:
1. Glial Proliferation: Increased glial cell density at the lesion site.
2. Vascular Changes: Hyalinization of the vessel walls, leading to the clinical "white line" appearance.
3. Membrane Formation: A condensed, overlying vitreous membrane that exerts chronic traction.

3. Clinical Indications, Presentation, and Staging

Standard Presentation

Patients with lattice degeneration are typically asymptomatic. The condition is usually identified during a routine dilated fundus examination. When symptoms do occur, they are generally related to the complications of the condition rather than the lattice itself.

Symptom Clinical Relevance
Photopsia (Flashes) Suggests acute vitreous traction/separation.
Floaters Indicates vitreous debris or hemorrhage.
Visual Field Defect Suggests a localized or extensive retinal detachment.

Clinical Grading and Classification

Lattice degeneration is categorized by its morphology and location:
* Classic Lattice: Spindle-shaped, crisscross white lines, pigmentary changes.
* Snail-Track Degeneration: A variant characterized by a more continuous, "frosted" appearance without the distinct crisscross vascular pattern.
* Radial Lattice: Less common; the lesions are oriented perpendicular to the ora serrata rather than parallel.

4. Diagnostic Evaluation and Differential Diagnosis

Key Diagnostic Tests

  1. Indirect Ophthalmoscopy with Scleral Depression: The gold standard for peripheral retinal evaluation. Essential for identifying the full extent of the lesion and associated tears.
  2. Goldmann Three-Mirror Contact Lens: Allows for high-magnification stereoscopic examination of the peripheral retina and the vitreous interface.
  3. Ultra-Widefield (UWF) Imaging: Increasingly used to document the extent of peripheral degeneration and monitor for subtle changes over time.
  4. OCT (Optical Coherence Tomography): Used to visualize the cross-sectional anatomy, confirming the thinning of the inner retinal layers and the presence of vitreous traction.

Differential Diagnosis

It is imperative to distinguish lattice degeneration from other peripheral retinal pathologies:
* Retinoschisis: Characterized by splitting of the retinal layers, usually dome-shaped, and lacks the white sclerotic vessels of lattice.
* Peripheral Cystoid Degeneration: Common, "honeycomb" appearance, usually located at the ora serrata; lacks the risk potential of lattice.
* Chorioretinal Scars: Usually secondary to past inflammation (e.g., toxoplasmosis) or trauma; typically involves deeper retinal layers and the choroid.

5. Risks, Side Effects, and Management Considerations

The Risk of Retinal Detachment

It is a common misconception that all lattice degeneration requires prophylactic treatment (e.g., laser retinopexy). In reality, the lifetime risk of a patient with lattice degeneration developing a retinal detachment is estimated to be less than 1%.

When to Consider Prophylaxis

Prophylactic laser or cryotherapy is generally reserved for high-risk patients, including:
* Patients with a history of retinal detachment in the fellow eye.
* Patients with a strong family history of retinal detachment.
* Patients undergoing cataract surgery (especially if high myopia is present).
* Presence of symptomatic flap tears at the margin of the lattice lesion.

Contraindications to Treatment

  • Asymptomatic lattice: Prophylactic treatment is generally not indicated and carries risks of its own, including iatrogenic retinal tears, macular edema, or the development of epiretinal membranes.

6. Long-Term Prognosis and Monitoring

The long-term prognosis for patients with lattice degeneration is generally excellent. The majority of patients remain stable throughout their lives without ever experiencing a retinal detachment. However, patients must be educated on the "Warning Signs" of a retinal detachment:
1. A sudden increase in the number of floaters.
2. Persistent flashes of light (photopsia).
3. A "curtain" or "shadow" moving across the peripheral visual field.

Regular monitoring (annually or biennially) is recommended for patients with extensive lattice or high myopia.

7. Massive FAQ Section

1. Is lattice degeneration a form of blindness?
No. Lattice degeneration is a thinning of the peripheral retina. While it is a risk factor for retinal detachment, it does not cause blindness on its own.

2. Can I exercise if I have lattice degeneration?
Yes. In most cases, patients can lead a normal, active lifestyle. High-impact sports should be discussed with an ophthalmologist if there are associated high-risk features like retinal tears.

3. Does lattice degeneration get worse with age?
The lesions themselves may change slowly over time, but the primary risk factor—vitreous liquefaction—is a natural part of the aging process (Posterior Vitreous Detachment).

4. Will I eventually need surgery?
Only if the lattice progresses to a retinal detachment or a symptomatic tear. The vast majority of people with lattice degeneration never require surgical intervention.

5. Is lattice degeneration hereditary?
There is a genetic predisposition, and it is frequently seen in patients with high myopia (nearsightedness) and certain connective tissue disorders like Stickler Syndrome.

6. What is the difference between lattice and a retinal hole?
Lattice is an area of thinning. A retinal hole is a full-thickness defect within or at the margin of that thinning. Holes are generally lower risk than flap tears.

7. Does screen time affect lattice degeneration?
There is no evidence that blue light or screen time exacerbates peripheral retinal thinning.

8. Is laser treatment painful?
Laser retinopexy is performed in the office under topical anesthesia. Most patients report only mild discomfort.

9. Can I fly or go scuba diving with lattice degeneration?
Generally, yes. However, if you have recently had a retinal detachment repair or have an active, high-risk retinal tear, you should consult your vitreoretinal specialist regarding pressure changes.

10. How often should I get my eyes checked?
If you have been diagnosed with lattice degeneration, an annual dilated fundus examination is typically recommended to ensure the peripheral retina remains stable.

Summary Table: Clinical Decision Making

Feature Low Risk High Risk
Symptomatology Asymptomatic Symptomatic (Flashes/Floaters)
Fellow Eye Status No history of detachment History of RRD in fellow eye
Lesion Morphology Small, atrophic holes Large, flap tears at margin
Management Observation Consider Laser Retinopexy
Follow-up Annual/Biennial 3–6 Months (or PRN)

Disclaimer: This guide is for educational purposes only and does not constitute medical advice. If you have been diagnosed with lattice degeneration or are experiencing symptoms such as flashes or floaters, consult an ophthalmologist or vitreoretinal specialist immediately for an in-person evaluation.

Treatment & Management Options

Share this guide: